McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Drug Retailers
- Sub-Industry: Health Care Distributors
- Symbol: NYSE:MCK
- CUSIP: 58155Q10
- Web: www.mckesson.com
Capitalization:- Market Cap: $31.20686 billion
- Outstanding Shares: 210,260,000
Average Prices:- 50 Day Moving Avg: $151.41
- 200 Day Moving Avg: $153.02
- 52 Week Range: $114.53 - $169.29
P/E:- Trailing P/E Ratio: 6.73
- Foreward P/E Ratio: 11.56
- P/E Growth: 2.90
Sales & Book Value:- Annual Revenue: $199.85 billion
- Price / Sales: 0.16
- Book Value: $53.76 per share
- Price / Book: 2.76
Dividend:- Annual Dividend: $1.36
- Dividend Yield: 0.9%
Profitability:- EBIDTA: $3.94 billion
- Net Margins: 2.42%
- Return on Equity: 25.76%
- Return on Assets: 4.34%
Debt:- Debt-to-Equity Ratio: 0.64%
- Current Ratio: 1.05%
- Quick Ratio: 0.62%
Misc:- Average Volume: 1.61 million shs.
- Beta: 1.16
- Short Ratio: 1.89
Frequently Asked Questions for McKesson Corporation (NYSE:MCK)
What is McKesson Corporation's stock symbol?
McKesson Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."
How often does McKesson Corporation pay dividends? What is the dividend yield for McKesson Corporation?
McKesson Corporation announced a quarterly dividend on Wednesday, July 26th. Shareholders of record on Friday, September 1st will be paid a dividend of $0.34 per share on Monday, October 2nd. This represents a $1.36 annualized dividend and a yield of 0.92%. The ex-dividend date is Wednesday, August 30th. This is a positive change from McKesson Corporation's previous quarterly dividend of $0.28. View McKesson Corporation's Dividend History.
How were McKesson Corporation's earnings last quarter?
McKesson Corporation (NYSE:MCK) announced its quarterly earnings data on Thursday, July, 27th. The company reported $2.46 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $2.81 by $0.35. The company earned $51.05 billion during the quarter, compared to analyst estimates of $51.22 billion. McKesson Corporation had a return on equity of 25.76% and a net margin of 2.42%. The business's revenue was up 2.7% on a year-over-year basis. During the same period in the previous year, the business posted $3.50 EPS. View McKesson Corporation's Earnings History.
When will McKesson Corporation make its next earnings announcement?
Where is McKesson Corporation's stock going? Where will McKesson Corporation's stock price be in 2017?
15 analysts have issued 1 year target prices for McKesson Corporation's shares. Their predictions range from $131.00 to $193.00. On average, they expect McKesson Corporation's stock price to reach $170.00 in the next year. View Analyst Ratings for McKesson Corporation.
What are analysts saying about McKesson Corporation stock?
Here are some recent quotes from research analysts about McKesson Corporation stock:
- 1. According to Zacks Investment Research, "Over the past three months, McKesson has been trading above the broader Medical/Dental – Supplies industry. Looking forward, management expects to gain with the gradually stabilizing generic and branded markets. The company recently posted stable numbers for the fourth-quarter fiscal 2017 (ended Mar 31, 2017) wherein earnings beat the Zacks Consensus Estimate, courtesy of a strong performance in the Distribution Solutions division. To boost growth the company has acquired CoverMyMeds for approximately $1.1 billion in the recent past. Also, cost-savings efforts remain encouraging. Furthermore, an inexpensive valuation and rising estimate revision trend for the current year indicates a pocket of opportunity for the stock. On the flip side, stiff competition, currency headwind and reimbursement issues remain challenges." (7/12/2017)
- 2. Citigroup Inc. analysts commented, "MCK yesterday announced the completion of its previously-announced agreement w/Change Healthcare (CHC) to create a new HCIT company retaining the same name, combining substantially all of CHC's business and the majority of MCK Tech. Solutions, less its EIS segment which will remain in MTS. Initial plans to merge assets were announced on 6/28/16. Mgmt provided color on the NewCo's financial implications, largely consistent with expectations, with recognition occurring on a 1-month lag (reducing guided F4Q17 adj EPS by ~$0.15). We update our estimates to fully reflect today's guidance on the NewCo, but currently assume a full FY18 RAD contribution to MCK. Net, we maintain our Buy, as headwinds appear to be stabilizing while the WMT contract should improve purchasing power, with some offsets given initial Change dilution and a likely F2H18 loss of RAD; $175 TP (+$6), ~13-14x CY17 EPS, ~17% ETR." (3/6/2017)
Who are some of McKesson Corporation's key competitors?
Some companies that are related to McKesson Corporation include Stryker Corporation (SYK), Aetna (AET), Anthem (ANTM), Shire PLC (SHPG), Fresenius SE (FSNUY), Regeneron Pharmaceuticals (REGN), Becton, Dickinson and Company (BDX), Takeda Pharmaceutical (TKPYY), Boston Scientific Corporation (BSX), Intuitive Surgical (ISRG), Vertex Pharmaceuticals Incorporated (VRTX), Humana (HUM), Express Scripts Holding Company (ESRX), Baxter International (BAX), Alexion Pharmaceuticals (ALXN), Zoetis (ZTS), Illumina (ILMN) and Fresenius Medical Care Corporation (FMS).
Who are McKesson Corporation's key executives?
McKesson Corporation's management team includes the folowing people:
- John Harvey Hammergren, Chairman of the Board, President, Chief Executive Officer
- James A. Beer, Chief Financial Officer, Executive Vice President
- Kathleen D. McElligott, Executive Vice President, Chief Technology Officer, Chief Information Officer
- Lori Ann Schechter, Executive Vice President, Chief Compliance Officer, General Counsel
- Jorge L. Figueredo, Executive Vice President - Human Resources
- Paul Coleman Julian, Executive Vice President, Group President
- Bansi Nagji, Executive Vice President - Corporate Strategy and Business Development
- Edward A. Mueller, Lead Independent Director
- Andrew D. Bryant, Independent Director
- N. Anthony Coles Jr. M.D., Independent Director
Who owns McKesson Corporation stock?
McKesson Corporation's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.29%), Vanguard Group Inc. (6.70%), State Street Corp (4.56%), FMR LLC (1.47%), Northern Trust Corp (1.21%) and Bank of New York Mellon Corp (1.13%). Company insiders that own McKesson Corporation stock include Erin M Lampert, James A Beer, John H Hammergren, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles, Nigel A Rees, Patrick Blake, Susan R Salka and Wayne A Budd. View Institutional Ownership Trends for McKesson Corporation.
Who sold McKesson Corporation stock? Who is selling McKesson Corporation stock?
McKesson Corporation's stock was sold by a variety of institutional investors in the last quarter, including Capital Research Global Investors, Ballentine Partners LLC, Ameriprise Financial Inc., FMR LLC, Schroder Investment Management Group, Epoch Investment Partners Inc., State Street Corp and State of New Jersey Common Pension Fund D. Company insiders that have sold McKesson Corporation stock in the last year include Erin M Lampert, John H Hammergren, M Christine Jacobs, Marie L/Ca Knowles and Wayne A Budd. View Insider Buying and Selling for McKesson Corporation.
Who bought McKesson Corporation stock? Who is buying McKesson Corporation stock?
McKesson Corporation's stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Harbour Capital Advisors LLC, Renaissance Technologies LLC, AJO LP, Kiltearn Partners LLP, Sterling Capital Management LLC, Canyon Capital Advisors LLC and Glenview Capital Management LLC. Company insiders that have bought McKesson Corporation stock in the last two years include Lori A Schechter and Susan R Salka. View Insider Buying and Selling for McKesson Corporation.
How do I buy McKesson Corporation stock?
Shares of McKesson Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is McKesson Corporation's stock price today?
One share of McKesson Corporation stock can currently be purchased for approximately $148.37.
MarketBeat Community Rating for McKesson Corporation (NYSE MCK)MarketBeat's community ratings are surveys of what our community members think about McKesson Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for McKesson Corporation (NYSE:MCK) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 1 Sell Rating, 7 Hold Ratings, 7 Buy Ratings |
| Consensus Rating: | Hold (Score: 2.40) |
| Consensus Price Target: | $170.00 (14.58% upside) |
Analysts' Ratings History for McKesson Corporation (NYSE:MCK)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 9/19/2017 | Royal Bank Of Canada | Initiated Coverage | Sector Perform -> Sector Perform | $168.00 | Low |  |
| 9/19/2017 | Robert W. Baird | Upgrade | Neutral -> Outperform | $175.00 -> $178.00 | Low | |
| 9/14/2017 | Morgan Stanley | Downgrade | Overweight -> Equal Weight | $184.00 -> $172.00 | High | |
| 9/8/2017 | Needham & Company LLC | Upgrade | Hold -> Buy | $179.00 | Low | |
| 8/29/2017 | Jefferies Group LLC | Set Price Target | Hold | $165.00 | Low | |
| 6/29/2017 | Leerink Swann | Boost Price Target | Market Perform | $170.00 | Medium | |
| 6/4/2017 | Barclays PLC | Set Price Target | Buy | $187.00 | Low | |
| 5/30/2017 | Mizuho | Boost Price Target | Neutral -> Neutral | $147.00 -> $168.00 | Low | |
| 5/23/2017 | J P Morgan Chase & Co | Upgrade | Neutral -> Overweight | $189.00 | Medium | |
| 4/17/2017 | Evercore ISI | Reiterated Rating | Outperform | $166.00 | Low | |
| 3/6/2017 | Citigroup Inc. | Boost Price Target | Buy | $169.00 -> $175.00 | N/A | |
| 3/3/2017 | Credit Suisse Group | Reiterated Rating | Sell | | N/A | |
| 1/18/2017 | Avondale Partners | Upgrade | Market Perform -> Outperform | $157.00 -> $193.00 | N/A | |
| 11/11/2016 | Standpoint Research | Downgrade | Buy -> Hold | | N/A | |
| 10/28/2016 | Deutsche Bank AG | Downgrade | Buy -> Hold | $196.00 -> $153.00 | N/A | |
| 9/19/2016 | Argus | Reiterated Rating | Hold | | N/A | |
| 9/16/2016 | Goldman Sachs Group, Inc. (The) | Downgrade | Buy -> Neutral | $210.00 -> $189.00 | N/A | |
| 6/30/2016 | Bank of America Corporation | Reiterated Rating | Hold | | N/A | |
| 6/29/2016 | FBR & Co | Reiterated Rating | Buy | $210.00 | N/A | |
| 6/1/2016 | Raymond James Financial, Inc. | Downgrade | Strong-Buy -> Outperform | | N/A | |
| 3/15/2016 | Cowen and Company | Downgrade | Outperform -> Market Perform | $208.00 -> $173.00 | N/A | |
(Data available from 9/20/2015 forward)
Earnings History for McKesson Corporation (NYSE:MCK)Earnings History by Quarter for McKesson Corporation (NYSE MCK)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/25/2017 | | $2.85 | | | | | N/A | |
| 7/27/2017 | Q1 2018 | $2.81 | $2.46 | $51.22 billion | $51.05 billion | View | N/A | |
| 5/18/2017 | Q4 17 | $3.04 | $3.39 | $49.48 billion | $48.71 billion | View | N/A | |
| 1/25/2017 | Q317 | $2.95 | $3.03 | $50.71 billion | $50.13 billion | View | N/A | |
| 10/27/2016 | Q217 | $3.05 | $2.94 | $24.16 billion | $49.96 billion | View | Listen | |
| 7/27/2016 | Q117 | $3.33 | $3.50 | $50.32 billion | $49.73 billion | View | Listen | |
| 5/4/2016 | Q416 | $3.14 | $2.44 | $46.83 billion | $46.68 billion | View | N/A | |
| 1/27/2016 | Q316 | $3.13 | $3.18 | $48.97 billion | $47.90 billion | View | Listen | |
| 10/29/2015 | Q216 | $2.99 | $3.31 | $47.85 billion | $48.60 billion | View | Listen | |
| 7/29/2015 | Q116 | $2.89 | $3.14 | $46.02 billion | $47.50 billion | View | Listen | |
| 5/12/2015 | Q415 | $2.75 | $2.94 | $45.00 billion | $44.93 billion | View | Listen | |
| 2/5/2015 | Q315 | $2.61 | $2.89 | $44.81 billion | $47.01 billion | View | N/A | |
| 10/28/2014 | Q215 | $2.73 | $2.79 | $42.99 billion | $44.76 billion | View | N/A | |
| 7/31/2014 | Q115 | $2.34 | $2.49 | $40.65 billion | $44.06 billion | View | N/A | |
| 5/12/2014 | Q414 | $2.40 | $2.55 | $35.89 billion | $38.14 billion | View | N/A | |
| 1/31/2014 | Q314 | $1.85 | $1.45 | $38.57 billion | $34.30 billion | View | N/A | |
| 10/24/2013 | Q214 | $2.03 | $2.27 | $32.16 billion | $33.00 billion | View | Listen | |
| 7/25/2013 | Q1 2014 | $1.71 | $2.07 | $32.60 billion | $32.20 billion | View | Listen | |
| 5/7/2013 | Q4 2013 | $2.30 | $1.45 | $32.01 billion | $30.62 billion | View | Listen | |
| 1/31/2013 | Q3 2013 | $1.62 | $1.41 | $30.81 billion | $31.19 billion | View | Listen | |
| 10/25/2012 | | $1.78 | $1.92 | | | View | N/A | |
| 7/26/2012 | | $1.48 | $1.55 | | | View | N/A | |
| 4/30/2012 | | $2.04 | $2.09 | | | View | N/A | |
| 1/30/2012 | | $1.38 | $1.40 | | | View | N/A | |
| 10/25/2011 | | $1.38 | $1.63 | | | View | N/A | |
| 7/28/2011 | | $1.10 | $1.27 | | | View | N/A | |
| 5/3/2011 | | $1.60 | $1.66 | | | View | N/A | |
| 1/31/2011 | | $1.12 | $1.12 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for McKesson Corporation (NYSE:MCK)2017 EPS Consensus Estimate: $12.80
2018 EPS Consensus Estimate: $11.96
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 2 | $3.36 | $3.40 | $3.38 |
| Q2 2017 | 2 | $3.10 | $3.10 | $3.10 |
| Q3 2017 | 2 | $2.85 | $3.46 | $3.16 |
| Q4 2017 | 3 | $2.99 | $3.51 | $3.17 |
| Q1 2018 | 2 | $2.85 | $2.88 | $2.87 |
| Q2 2018 | 2 | $2.80 | $2.82 | $2.81 |
| Q3 2018 | 2 | $2.80 | $2.90 | $2.85 |
| Q4 2018 | 2 | $3.08 | $3.78 | $3.43 |
(Data provided by Zacks Investment Research)
Current Dividend Information for McKesson Corporation (NYSE:MCK)| Next Dividend: | 10/2/2017 |
| Annual Dividend: | $1.36 |
| Dividend Yield: | 0.92% |
| Dividend Growth: | 10.10% (3 Year Average) |
| Payout Ratio: | 6.07% (Trailing 12 Months of Earnings)
11.24% (Based on This Year's Estimates)
10.60% (Based on Next Year's Estimates)
|
| Track Record: | 4 Years of Consecutive Dividend Growth |
Dividend History by Quarter for McKesson Corporation (NYSE MCK)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 7/26/2017 | quarterly | $0.34 | 0.84% | 8/30/2017 | 9/1/2017 | 10/2/2017 |
| 5/24/2017 | quarterly | $0.28 | 0.69% | 6/1/2017 | 6/5/2017 | 7/3/2017 |
| 1/25/2017 | quarterly | $0.28 | 0.81% | 2/27/2017 | 3/1/2017 | 4/3/2017 |
| 10/27/2016 | quarterly | $0.28 | 0.9% | 11/29/2016 | 12/1/2016 | 1/2/2017 |
| 7/26/2016 | quarterly | $0.28 | 0.57% | 8/30/2016 | 9/1/2016 | 10/3/2016 |
| 5/25/2016 | quarterly | $0.28 | 0.62% | 6/2/2016 | 6/6/2016 | 7/1/2016 |
| 1/27/2016 | quarterly | $0.28 | 0.7% | 2/26/2016 | 3/1/2016 | 4/1/2016 |
| 10/30/2015 | quarterly | $0.28 | 0.62% | 11/27/2015 | 12/1/2015 | 1/4/2016 |
| 7/29/2015 | quarterly | $0.28 | 0.52% | 8/28/2015 | 9/1/2015 | 10/1/2015 |
| 5/27/2015 | quarterly | $0.24 | 0.4% | 6/4/2015 | 6/8/2015 | 7/1/2015 |
| 1/29/2015 | quarterly | $0.24 | 0.44% | 2/26/2015 | 3/2/2015 | 4/1/2015 |
| 10/21/2014 | quarterly | $0.24 | 0.49% | 11/26/2014 | 12/1/2014 | 1/2/2015 |
| 7/30/2014 | quarterly | $0.24 | 0.49% | 8/28/2014 | 9/2/2014 | 10/1/2014 |
| 5/28/2014 | quarterly | $0.24 | 0.51% | 6/5/2014 | 6/9/2014 | 7/1/2014 |
| 1/29/2014 | quarterly | $0.24 | 0.54% | 2/27/2014 | 3/3/2014 | 4/1/2014 |
| 10/25/2013 | quarterly | $0.24 | 0.63% | 11/27/2013 | 12/2/2013 | 1/2/2014 |
| 7/25/2013 | quarterly | $0.24 | 0.77% | 8/29/2013 | 9/3/2013 | 10/1/2013 |
| 5/22/2013 | quarterly | $0.22 | 0.68% | 6/5/2013 | 6/7/2013 | 7/1/2013 |
| 1/30/2013 | quarterly | $0.20 | 0.76% | 2/27/2013 | 3/1/2013 | 4/1/2013 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for McKesson Corporation (NYSE:MCK)Insider Ownership Percentage: 1.20%
Institutional Ownership Percentage: 85.16%
Insider Trades by Quarter for McKesson Corporation (NYSE:MCK)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 9/7/2017 | Erin M. Lampert | SVP | Sell | 900 | $155.65 | $140,085.00 | |
| 8/21/2017 | M Christine Jacobs | Director | Sell | 1,083 | $145.43 | $157,500.69 | |
| 7/31/2017 | Marie L/Ca Knowles | Director | Sell | 1,083 | $162.55 | $176,041.65 | |
| 6/1/2017 | John H Hammergren | Chairman | Sell | 38,619 | $163.76 | $6,324,247.44 | |
| 5/31/2017 | Erin M Lampert | SVP | Sell | 809 | $160.66 | $129,973.94 | |
| 5/30/2017 | Erin M Lampert | SVP | Sell | 404 | $160.53 | $64,854.12 | |
| 5/30/2017 | John H Hammergren | Chairman | Sell | 19,316 | $162.31 | $3,135,179.96 | |
| 3/29/2017 | John H Hammergren | Chairman | Sell | 100,500 | $150.44 | $15,119,220.00 | |
| 3/2/2017 | John H Hammergren | Chairman | Sell | 100,500 | $150.49 | $15,124,245.00 | |
| 12/5/2016 | Wayne A. Budd | Director | Sell | 723 | $145.77 | $105,391.71 | |
| 11/30/2016 | Lori A Schechter | EVP | Buy | 692 | $144.52 | $100,007.84 | |
| 11/2/2016 | Susan R Salka | Director | Buy | 1,000 | $136.35 | $136,350.00 | |
| 10/31/2016 | Erin M Lampert | SVP | Sell | 921 | $123.99 | $114,194.79 | |
| 10/3/2016 | Erin M. Lampert | SVP | Sell | 1,739 | $165.94 | $288,569.66 | |
| 9/12/2016 | John H Hammergren | Chairman | Sell | 100,500 | $180.77 | $18,167,385.00 | |
| 9/12/2016 | Wayne A Budd | Director | Sell | 2,309 | $179.70 | $414,927.30 | |
| 9/6/2016 | John H Hammergren | Chairman | Sell | 100,500 | $184.22 | $18,514,110.00 | |
| 8/22/2016 | M Christine Jacobs | Director | Sell | 915 | $193.78 | $177,308.70 | |
| 8/1/2016 | Marie L/Ca Knowles | Director | Sell | 915 | $192.73 | $176,347.95 | |
| 7/14/2016 | James A Beer | CFO | Sell | 5,500 | $199.00 | $1,094,500.00 | |
| 5/25/2016 | John H Hammergren | CEO | Sell | 37,420 | $182.87 | $6,842,995.40 | |
| 5/25/2016 | Patrick Blake | EVP | Sell | 6,322 | $182.87 | $1,156,104.14 | |
| 5/24/2016 | John H Hammergren | CEO | Sell | 18,709 | $182.06 | $3,406,160.54 | |
| 5/24/2016 | Lori A Schechter | EVP | Sell | 107 | $182.06 | $19,480.42 | |
| 5/23/2016 | John H Hammergren | CEO | Sell | 18,718 | $179.33 | $3,356,698.94 | |
| 5/23/2016 | Patrick Blake | EVP | Sell | 3,162 | $179.33 | $567,041.46 | |
| 5/10/2016 | John H Hammergren | CEO | Sell | 101,833 | $170.71 | $17,383,911.43 | |
| 4/25/2016 | John H Hammergren | CEO | Sell | 101,833 | $176.81 | $18,005,092.73 | |
| 4/4/2016 | John H Hammergren | CEO | Sell | 45,300 | $159.00 | $7,202,700.00 | |
| 3/15/2016 | Nigel A Rees | SVP | Sell | 6,000 | $157.59 | $945,540.00 | |
| 2/2/2016 | Susan R Salka | Director | Buy | 1,000 | $156.21 | $156,210.00 | |
| 2/1/2016 | Lori A. Schechter | EVP | Sell | 2,476 | $159.73 | $395,491.48 | |
| 1/4/2016 | John H. Hammergren | CEO | Sell | 101,833 | $194.11 | $19,766,803.63 | |
| 12/1/2015 | John H. Hammergren | CEO | Sell | 101,833 | $190.06 | $19,354,379.98 | |
| 11/24/2015 | John H. Hammergren | CEO | Sell | 56,533 | $190.01 | $10,741,835.33 | |
| 10/12/2015 | John H. Hammergren | CEO | Sell | 101,835 | $190.51 | $19,400,585.85 | |
| 8/13/2015 | Paul C Julian | EVP | Sell | 55,666 | $214.54 | $11,942,583.64 | |
| 7/15/2015 | Paul C Julian | EVP | Sell | 27,833 | $234.04 | $6,514,035.32 | |
| 7/14/2015 | Paul C Julian | EVP | Sell | 27,833 | $232.86 | $6,481,192.38 | |
| 6/17/2015 | Paul C Julian | EVP | Sell | 55,668 | $234.06 | $13,029,652.08 | |
| 5/28/2015 | John H Hammergren | CEO | Sell | 60,000 | $238.53 | $14,311,800.00 | |
| 5/28/2015 | Lori A Schechter | EVP | Sell | 1,468 | $238.22 | $349,706.96 | |
| 5/26/2015 | John H Hammergren | CEO | Sell | 30,062 | $238.97 | $7,183,916.14 | |
| 5/26/2015 | Paul C Julian | EVP | Sell | 15,289 | $238.97 | $3,653,612.33 | |
| 5/22/2015 | Jorge Figueredo | EVP | Sell | 20,775 | $240.11 | $4,988,285.25 | |
| 5/15/2015 | Jorge Figueredo | EVP | Sell | 8,525 | $240.00 | $2,046,000.00 | |
| 2/17/2015 | Randall N Spratt | EVP | Sell | 44,523 | $225.00 | $10,017,675.00 | |
| 2/12/2015 | Randall N Spratt | EVP | Sell | 7,477 | $225.00 | $1,682,325.00 | |
| 2/10/2015 | Alton F Irby III | Director | Sell | 5,000 | $220.76 | $1,103,800.00 | |
| 2/10/2015 | Nigel A Rees | Major Shareholder | Sell | 9,000 | $220.42 | $1,983,780.00 | |
| 1/28/2015 | John H Hammergren | CEO | Sell | 64,521 | $219.52 | $14,163,649.92 | |
| 1/26/2015 | Brian Scott Tyler | EVP | Sell | 5,431 | $216.62 | $1,176,463.22 | |
| 1/26/2015 | John H Hammergren | CEO | Sell | 35,479 | $219.07 | $7,772,384.53 | |
| 1/7/2015 | John H Hammergren | CEO | Sell | 77,100 | $214.00 | $16,499,400.00 | |
| 12/8/2014 | John H Hammergren | CEO | Sell | 12,200 | $214.01 | $2,610,922.00 | |
| 11/28/2014 | Patrick Blake | EVP | Sell | 19,000 | $210.00 | $3,990,000.00 | |
| 11/24/2014 | John H Hammergren | CEO | Sell | 100,000 | $209.25 | $20,925,000.00 | |
| 11/12/2014 | Paul C Julian | EVP | Sell | 74,666 | $202.51 | $15,120,611.66 | |
| 10/31/2014 | Patrick Blake | EVP | Sell | 38,000 | $204.68 | $7,777,840.00 | |
| 10/8/2014 | Paul C Julian | EVP | Sell | 74,667 | $195.86 | $14,624,278.62 | |
| 10/7/2014 | John H Hammergren | CEO | Sell | 100,000 | $197.28 | $19,728,000.00 | |
| 9/10/2014 | Paul C Julian | EVP | Sell | 74,667 | $196.76 | $14,691,478.92 | |
| 8/29/2014 | Jorge Figueredo | EVP | Sell | 24,500 | $195.00 | $4,777,500.00 | |
| 8/8/2014 | M Christine Jacobs | Director | Sell | 2,619 | $189.88 | $497,295.72 | |
| 8/5/2014 | Marie L/Ca Knowles | Director | Sell | 785 | $192.10 | $150,798.50 | |
| 6/2/2014 | Patrick Blake | EVP | Sell | 15,000 | $190.00 | $2,850,000.00 | |
| 5/29/2014 | Paul C Julian | EVP | Sell | 21,057 | $186.89 | $3,935,342.73 | |
| 5/28/2014 | Alton F Irby III | Director | Sell | 4,000 | $182.73 | $730,920.00 | |
| 5/28/2014 | John H Hammergren | CEO | Sell | 125,596 | $183.31 | $23,023,002.76 | |
| 5/28/2014 | Jorge Figueredo | EVP | Sell | 20,542 | $183.30 | $3,765,348.60 | |
| 5/27/2014 | Brian Scott Tyler | EVP | Sell | 3,916 | $183.30 | $717,802.80 | |
| 5/22/2014 | Brian Scott Tyler | EVP | Sell | 8,250 | $184.17 | $1,519,402.50 | |
| 3/21/2014 | Jorge Figueredo | EVP | Sell | 23,684 | $185.81 | $4,400,724.04 | |
| 3/10/2014 | Patrick Blake | EVP | Sell | 38,750 | $180.36 | $6,988,950.00 | |
| 2/4/2014 | Brian Scott Tyler | EVP | Sell | 6,250 | $169.68 | $1,060,500.00 | |
| 1/22/2014 | Alton Irby III | Director | Sell | 1,300 | $167.98 | $218,374.00 | |
| 11/1/2013 | Nigel A Rees | CFO | Sell | 7,000 | $158.72 | $1,111,040.00 | |
| 10/29/2013 | Brian Scott Tyler | EVP | Sell | 8,250 | $153.44 | $1,265,880.00 | |
| 10/11/2013 | Brian Scott Tyler | EVP | Sell | 9,000 | $138.51 | $1,246,590.00 | |
| 10/9/2013 | Paul Julian | EVP | Sell | 84,000 | $134.04 | $11,259,360.00 | |
| 10/8/2013 | Brian Scott Tyler | EVP | Sell | 9,000 | $138.00 | $1,242,000.00 | |
| 9/11/2013 | Paul C Julian | EVP | Sell | 84,000 | $126.20 | $10,600,800.00 | |
| 8/7/2013 | Paul Julian | EVP | Sell | 84,000 | $123.29 | $10,356,360.00 | |
| 8/6/2013 | Marie L/Ca Knowles | Director | Sell | 1,223 | $123.54 | $151,089.42 | |
| 7/30/2013 | Brian Scott Tyler | EVP | Sell | 6,250 | $123.94 | $774,625.00 | |
| 6/19/2013 | Paul C Julian | EVP | Sell | 84,750 | $114.89 | $9,736,927.50 | |
| 6/14/2013 | David M Lawrence | Director | Sell | 7,500 | $114.28 | $857,100.00 | |
| 6/14/2013 | Jorge Figueredo | EVP | Sell | 6,250 | $115.00 | $718,750.00 | |
| 6/10/2013 | Jorge Figueredo | EVP | Sell | 10,000 | $115.00 | $1,150,000.00 | |
| 6/4/2013 | Jorge Figueredo | EVP | Sell | 22,500 | $113.63 | $2,556,675.00 | |
| 5/30/2013 | Laureen Seeger | EVP | Sell | 57,750 | $114.89 | $6,634,897.50 | |
| 5/29/2013 | John H Hammergren | CEO | Sell | 230,484 | $115.21 | $26,554,061.64 | |
| 5/29/2013 | Randall N Spratt | EVP | Sell | 32,226 | $115.21 | $3,712,757.46 | |
| 5/28/2013 | Brian Scott Tyler | EVP | Sell | 6,023 | $116.33 | $700,655.59 | |
| 5/28/2013 | Jeffrey C Campbell | CFO | Sell | 73,102 | $116.33 | $8,503,955.66 | |
| 5/24/2013 | Laureen Seeger | EVP | Sell | 17,250 | $116.50 | $2,009,625.00 | |
| 5/22/2013 | Laureen Seeger | EVP | Sell | 17,250 | $118.13 | $2,037,742.50 | |
| 5/20/2013 | Brian Scott Tyler | EVP | Sell | 5,000 | $117.81 | $589,050.00 | |
| 5/15/2013 | Nigel A Rees | VP | Sell | 8,000 | $116.00 | $928,000.00 | |
| 5/10/2013 | Brian Scott Tyler | EVP | Sell | 6,250 | $115.59 | $722,437.50 | |
| 5/10/2013 | John H Hammergren | CEO | Sell | 75,000 | $115.30 | $8,647,500.00 | |
| 1/18/2013 | Jorge Figueredo | EVP | Sell | 2,500 | $103.22 | $258,050.00 | |
| 1/17/2013 | Laureen Seeger | EVP | Sell | 17,250 | $103.00 | $1,776,750.00 | |
| 9/4/2012 | Paul C Julian | EVP | Sell | 36,250 | $87.02 | $3,154,475.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for McKesson Corporation (NYSE:MCK)
Latest Headlines for McKesson Corporation (NYSE:MCK)
| Source: |
|
| Date | Headline |
|---|
 | Analyst 'Takes A Flyer' On McKesson, Upgrades Ahead Of Earnings
finance.yahoo.com - September 20 at 6:09 AM |
 | Robert W. Baird Upgrades McKesson Corporation (MCK) to "Outperform"
www.americanbankingnews.com - September 20 at 12:08 AM |
| Royal Bank Of Canada Initiates Coverage on McKesson Corporation (MCK)
www.americanbankingnews.com - September 19 at 7:38 AM |
| McKesson Corporation (MCK) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - September 17 at 5:06 PM |
| McKesson Corporation (MCK) Downgraded by Morgan Stanley
www.americanbankingnews.com - September 16 at 9:04 PM |
 | McKesson Increases Hurricane Relief Commitment to $600,000 ... - Business Wire (press release)
www.businesswire.com - September 15 at 6:20 AM |
 | Stocks slip as tech and healthcare stumble
www.latimes.com - September 14 at 11:34 AM |
 | Markets Right Now: Tech and health care stocks stumble
marketbeat.com - September 14 at 10:06 AM |
| McKesson Corp. – Value Analysis (NYSE:MCK) : September 14, 2017
finance.yahoo.com - September 14 at 7:32 AM |
| McKesson Corp. breached its 50 day moving average in a Bullish Manner : MCK-US : September 12, 2017
finance.yahoo.com - September 13 at 6:22 AM |
| Head-To-Head Contrast: McKesson Corporation (MCK) and MWI Veterinary Supply (MWIV)
www.americanbankingnews.com - September 12 at 12:30 PM |
| McKesson Corporation Expected to Earn Q4 2018 Earnings of $3.78 Per Share (MCK)
www.americanbankingnews.com - September 11 at 9:42 AM |
 | Vitaliy Katsenelson's Contrarian Edge: This drug industry leader could be healthy for your stock portfolio
www.marketwatch.com - September 11 at 5:57 AM |
| This drug industry leader could be healthy for your stock portfolio
finance.yahoo.com - September 11 at 5:40 AM |
| Hurricane Irma: McKesson Prepares to Support Healthcare Providers, Pharmacies and First Responders
www.businesswire.com - September 9 at 6:05 AM |
 | McKesson Ventures Leads $25 Million Financing Round For Truveris
seekingalpha.com - September 9 at 6:05 AM |
| McKesson Corporation (MCK) Expected to Post Quarterly Sales of $51.60 Billion
www.americanbankingnews.com - September 9 at 3:44 AM |
| McKesson Corporation (MCK) Upgraded to "Buy" at Needham & Company LLC
www.americanbankingnews.com - September 8 at 9:18 PM |
| Insider Selling: McKesson Corporation (MCK) SVP Sells 900 Shares of Stock
www.americanbankingnews.com - September 8 at 8:20 PM |
| Contrasting MWI Veterinary Supply (MWIV) & McKesson Corporation (MCK)
www.americanbankingnews.com - September 4 at 12:34 PM |
| Reviewing McKesson Corporation (MCK) & MWI Veterinary Supply (MWIV)
www.americanbankingnews.com - September 1 at 9:03 AM |
| McKesson Commits More than $300,000 in Relief Support for ... - Business Wire (press release)
www.businesswire.com - September 1 at 3:48 AM |
| How World's Largest Drug Distributor Is Helping Harvey Victims Treat Snakebites
finance.yahoo.com - September 1 at 3:48 AM |
 | Oversold Conditions For McKesson (MCK)
www.nasdaq.com - August 30 at 6:27 AM |
| McKesson Corporation (MCK) Given a $165.00 Price Target by Jefferies Group LLC Analysts
www.americanbankingnews.com - August 29 at 9:28 PM |
 | Digital Health Market in Asia-Pacific to Witness Fastest Growth by 2022, Globally: P&S Market Research
globenewswire.com - August 28 at 5:30 AM |
| McKesson Heavily Oversold At $147 - Seeking Alpha
seekingalpha.com - August 25 at 8:19 AM |
 | Pharmacy Automation Devices Market: Global Trends, Size, Share, Growth Drivers, Opportunities and 2021 Forecasts Discussed in New Research Report
www.bizjournals.com - August 24 at 9:04 AM |
| McKesson Corporation (MCK) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - August 23 at 6:46 PM |
| McKesson Corporation to Present at the Morgan Stanley Global Healthcare Conference - Business Wire (press release)
www.businesswire.com - August 22 at 8:51 PM |
| McKesson Corporation to Present at the Morgan Stanley Global Healthcare Conference
finance.yahoo.com - August 22 at 8:51 PM |
| McKesson Corporation (MCK) Director M Christine Jacobs Sells 1,083 Shares
www.americanbankingnews.com - August 22 at 7:34 PM |
| Analysts Expect McKesson Corporation (MCK) Will Post Quarterly Sales of $51.60 Billion
www.americanbankingnews.com - August 22 at 1:56 PM |
| Earnings Review and Free Research Report: Cardinal Health Adjusted Diluted EPS increased 15%
finance.yahoo.com - August 21 at 8:16 AM |
| McKesson Corporation (MCK) Downgraded to "Strong Sell" at BidaskClub
www.americanbankingnews.com - August 19 at 4:38 PM |
| McKesson Banks on Distribution Business Amid Pricing Woes - Nasdaq
www.nasdaq.com - August 18 at 6:36 AM |
| Head to Head Contrast: MWI Veterinary Supply (MWIV) vs. McKesson Corporation (MCK)
www.americanbankingnews.com - August 17 at 10:30 AM |
| Allscripts Stock Climbs, Cantor Upgrades After McKesson Deal
finance.yahoo.com - August 16 at 6:02 AM |
| McKesson (MCK) Shares Cross Below 200 DMA
www.nasdaq.com - August 15 at 1:22 AM |
| Drug Distributor Has Some Upside
finance.yahoo.com - August 15 at 1:22 AM |
| ETFs with exposure to McKesson Corp. : August 14, 2017
finance.yahoo.com - August 15 at 1:22 AM |
| See what the IHS Markit Score report has to say about McKesson Corp.
finance.yahoo.com - August 12 at 7:43 PM |
| McKesson: Why I'm Long
seekingalpha.com - August 11 at 6:22 AM |
| Allscripts to acquire McKesson's Enterprise Information Solutions business - GlobeNewswire (press release)
globenewswire.com - August 5 at 7:26 PM |
 | BRIEF-James Beer, EVP, CFO of Mckesson Corporation, joins Alaska Air board of directors
www.reuters.com - August 5 at 2:33 AM |
 | James Beer, EVP, CFO of McKesson Corporation, joins Alaska Air Group Board of Directors - PR Newswire (press release)
www.prnewswire.com - August 4 at 1:27 AM |
| Allscripts buys McKesson's hospital and health system IT unit for $185M
seekingalpha.com - August 3 at 6:28 PM |
| Baron & Budd, Greene Ketchum, Levin Papantonio File Suit Against Pharmaceutical Distributors for Role in Creating Opioid Crisis in Four Ohio Counties
www.businesswire.com - August 3 at 4:40 AM |
| McKesson: Margin Of Safety - Seeking Alpha
seekingalpha.com - August 2 at 4:06 AM |
| How Safe Is McCormick's Dividend?
finance.yahoo.com - August 2 at 4:06 AM |
McKesson Corporation (MCK) Chart for Wednesday, September, 20, 2017
